GMAB

Q: What is the price of Genmab (GMAB) today?

The current price of Genmab (GMAB) is $ 25.10, representing a 12.81% gain over the past year. The stock began the year trading around $ 30.80 and is currently priced at $ 25.10. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Genmab (GMAB) pay dividends?

Genmab (GMAB) did not pay dividends over the past year.

Q: Is Genmab (GMAB) a good investment?

Genmab (GMAB) is currently trading at $ 25.10 with a P/E ratio of 19.33. This represents a 2,360% premium compared to its historical average P/E. Over the past year, the stock has gained 12.81 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 12.81%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Genmab A/S

Price

$ 25.10

return (12m)

12.81%

p/e

19.33

p/bv

2.79

DIVIDEND YIELD

0.00%

GMAB price

Genmab

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GMAB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-5.03%

3 months

-8.33%

1 year

12.81%

2 years

-9.61%

5 years

-42.62%

10 years

45.83%

Fundamentals GMAB

review the fundamentals of Genmab shares

P/E

19.33

Sector: 10.75 Industry: 4.93

P/S (PSR)

4.07

Sector: 0.99 Industry: 0.31

P/BV

2.79

Sector: 1.60 Industry: 0.68

DIVIDEND YIELD (DY)

0.00%

Sector: 0.39% Industry: 0.24%

ROA

6.63%

Sector: 0.93% Industry: -3.59%

ROE

14.45%

Sector: 3.73% Industry: -10.36%

ROIC

6.31%

Sector: -7.76% Industry: -10.10%

NET MARGIN

21.05%

Sector: 1.80% Industry: -2.28%

GROSS MARGIN

93.31%

Sector: 38.88% Industry: 32.14%

OPERATING MARGIN

32.99%

Sector: 5.69% Industry: 0.12%

EV/EBITDA

12.34

Sector: 5.21 Industry: 2.84

EV/EBIT

13.20

Sector: 7.14 Industry: 3.87

PRICE-TO-ASSETS

1.28

Sector: 0.78 Industry: 0.32

BVPS

9.00

Sector: 10.26 Industry: 11.37

EPS

1.30

Sector: 0.75 Industry: 0.30

EQUITY-TO-ASSETS RATIO

0.46

Sector: 0.31 Industry: 0.23

LIABILITIES / ASSETS

0.54

Sector: 0.60 Industry: 0.59

CAGR REVENUE 5 YEARS

24.74%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

12.62%

Sector: - Industry: -

FAIR VALUE OF Genmab ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current Price

$ 25.10

Fair Value

$ 16.22

Upside Return potential.

-35.36%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals GMAB

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
AMZN	29.11	5.98	20.55%	0.00%	$ 2.64 T	12.22%
MELI	42.45	11.19	26.37%	0.00%	$ 81.51 B	6.04%
DIS	15.57	1.52	9.73%	1.26%	$ 174.76 B	11.54%
VZ	11.00	1.82	16.57%	6.09%	$ 190.78 B	12.46%
MCD	22.77	-153.69	-674.81%	2.61%	$ 197.64 B	31.62%
WMT	41.49	9.34	22.52%	0.82%	$ 943.31 B	3.13%
V	27.63	17.23	62.35%	0.80%	$ 614.46 B	51.68%
COST	48.82	12.88	26.38%	0.55%	$ 431.51 B	3.01%
NFLX	25.95	11.15	42.97%	0.00%	$ 347.05 B	28.52%
T	7.35	1.26	17.09%	4.88%	$ 161.46 B	17.47%
BABA	19.20	1.72	8.96%	1.65%	$ 281.22 B	10.10%
SBUX	72.63	-12.84	-17.68%	2.59%	$ 108.63 B	3.89%
HD	22.05	22.27	100.99%	2.97%	$ 308.92 B	8.41%
CMCSA	4.56	0.97	21.23%	5.54%	$ 85.68 B	15.00%
TGT	16.13	3.39	21.04%	3.72%	$ 55.65 B	3.24%
TBB	6.44	1.33	20.57%	6.47%	$ 145.39 B	17.83%
CMG	26.23	15.82	60.31%	0.00%	$ 38.08 B	11.96%
TMUS	19.46	3.67	18.87%	2.04%	$ 205.18 B	11.65%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

GMAB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Genmab

Genmab A/S

Average Investor10 user rating

4.0 (9 people)

United States

28 years

Founded: 1998

2019

Time since IPO - 7 years

781

Employees

Genmab A/S (United States) is listed on the Nasdaq and has a market capitalization of $15.87 Billions, with shareholders equity totaling $5.68 Billions.

The company employs approximately 781 people and operates in the Services sector, within the Commercial Services industry.

Over the past 12 months, Genmab A/S reported $3.90 Billions in revenue, generating net income of $821.00 Millions.

Key financial metrics include a P/E ratio of 19.33, a price-to-book (P/B) ratio of 2.79, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker GMAB.

Market cap

$ 15.87 Billions

Net worth

$ 5.68 Billions

$ 5,682,000,000.00

Assets

$ 12.38 Billions

$ 12,376,000,000.00

Total Shares Outstanding

631.00 Millions

631,000,000

Average Daily Trading Volume

$ 1.90 Million

$ 1,904,166.00

Sector

Services

Industry

Commercial Services

GMAB

GMAB revenue and profits

Financial Results GMAB

DRAG THE FRAME TO SEE MORE DATA

GMAB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

AMZN - Amazon

$ 244.19 12,21% (12M)

P/E

29.11

0.00%

ROE

20.55%

P/BV

5.98

WMT - Walmart

$ 118.88 23,71% (12M)

P/E

41.49

0.82%

ROE

22.52%

P/BV

9.34

COST - Costco Wholesale

$ 968.59 --3,29% (12M)

P/E

48.82

0.55%

ROE

26.38%

P/BV

12.88

JD - JD.com

$ 28.73 --12,06% (12M)

P/E

20.19

3.40%

ROE

4.80%

P/BV

0.97

HD - Home Depot

$ 321.33 --9,78% (12M)

P/E

22.05

2.97%

ROE

100.99%

P/BV

22.27

WBA - Walgreens Boots Alliance

$ - -0,00% (12M)

P/E

-1.76

4.17%

ROE

-80.35%

P/BV

1.42

BABA - Alibaba

$ 119.70 --1,79% (12M)

P/E

19.20

1.65%

ROE

8.96%

P/BV

1.72

KR - Kroger

$ 62.99 --1,71% (12M)

P/E

39.48

2.20%

ROE

17.12%

P/BV

6.76